Non-myeloablative Autologous Haematopoietic Stem Cell Transplantation with Consolidation Therapy using Mitoxantrone as a Treatment Option in Multiple Sclerosis Patients

Awards Nomination 20+ Million Readerbase

Research Article - (2011) Volume 1, Issue 1

Novik AA¹^*, Kuznetsov AN², Melnichenko VY³, Fedorenko DA⁴, Ionova TI⁵ and Gorodokin GV⁶: ¹Department of Haematology and Cellular Therapy, Pirogov National Medical Surgical Center, Moscow, Russia; ²Department of Neurology, Pirogov National Medical Surgical Center, Moscow, Russia; ³Department of Haematology and Cellular Therapy, Pirogov National Medical Surgical Center, Moscow, Russia; ⁴Department of Hematology and Cellular Therapy, Pirogov National Medical Surgical Center, Moscow, Russia; ⁵Department of Hematology and Cellular Therapy, Pirogov National Medical Surgical Center, Moscow, Russia; ⁶Health Outcomes Department, New Jersey Center for Quality of Life and Health Outcome Research, NJ, USA

^*Corresponding Author: